PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
NARI vs. IMVT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between NARI and IMVT is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.2

Performance

NARI vs. IMVT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Inari Medical, Inc. (NARI) and Immunovant, Inc. (IMVT). The values are adjusted to include any dividend payments, if applicable.

-40.00%-20.00%0.00%20.00%40.00%60.00%80.00%NovemberDecember2025FebruaryMarchApril
88.12%
-24.29%
NARI
IMVT

Key characteristics

Fundamentals

Market Cap

NARI:

$4.68B

IMVT:

$2.57B

EPS

NARI:

-$1.35

IMVT:

-$2.62

PS Ratio

NARI:

8.15

IMVT:

0.00

PB Ratio

NARI:

10.77

IMVT:

7.30

Total Revenue (TTM)

NARI:

$299.21M

IMVT:

$0.00

Gross Profit (TTM)

NARI:

$255.82M

IMVT:

-$80.00K

EBITDA (TTM)

NARI:

-$23.82M

IMVT:

-$324.06M

Returns By Period


NARI

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

IMVT

YTD

-38.84%

1M

-19.76%

6M

-48.59%

1Y

-46.50%

5Y*

-3.92%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

NARI vs. IMVT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NARI
The Risk-Adjusted Performance Rank of NARI is 7272
Overall Rank
The Sharpe Ratio Rank of NARI is 7171
Sharpe Ratio Rank
The Sortino Ratio Rank of NARI is 7373
Sortino Ratio Rank
The Omega Ratio Rank of NARI is 7474
Omega Ratio Rank
The Calmar Ratio Rank of NARI is 7272
Calmar Ratio Rank
The Martin Ratio Rank of NARI is 6969
Martin Ratio Rank

IMVT
The Risk-Adjusted Performance Rank of IMVT is 77
Overall Rank
The Sharpe Ratio Rank of IMVT is 66
Sharpe Ratio Rank
The Sortino Ratio Rank of IMVT is 88
Sortino Ratio Rank
The Omega Ratio Rank of IMVT is 1010
Omega Ratio Rank
The Calmar Ratio Rank of IMVT is 1212
Calmar Ratio Rank
The Martin Ratio Rank of IMVT is 22
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

NARI vs. IMVT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Inari Medical, Inc. (NARI) and Immunovant, Inc. (IMVT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for NARI, currently valued at 1.90, compared to the broader market-2.00-1.000.001.002.003.00
NARI: 1.90
IMVT: -0.98
The chart of Sortino ratio for NARI, currently valued at 3.60, compared to the broader market-6.00-4.00-2.000.002.004.00
NARI: 3.60
IMVT: -1.44
The chart of Omega ratio for NARI, currently valued at 1.48, compared to the broader market0.501.001.502.00
NARI: 1.48
IMVT: 0.83
The chart of Calmar ratio for NARI, currently valued at 1.48, compared to the broader market0.001.002.003.004.00
NARI: 1.48
IMVT: -0.67
The chart of Martin ratio for NARI, currently valued at 7.72, compared to the broader market-5.000.005.0010.0015.0020.00
NARI: 7.72
IMVT: -1.96


Rolling 12-month Sharpe Ratio-1.50-1.00-0.500.000.501.001.502.00NovemberDecember2025FebruaryMarchApril
1.90
-0.98
NARI
IMVT

Dividends

NARI vs. IMVT - Dividend Comparison

Neither NARI nor IMVT has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

NARI vs. IMVT - Drawdown Comparison


-70.00%-60.00%-50.00%-40.00%NovemberDecember2025FebruaryMarchApril
-36.49%
-71.26%
NARI
IMVT

Volatility

NARI vs. IMVT - Volatility Comparison

The current volatility for Inari Medical, Inc. (NARI) is 0.00%, while Immunovant, Inc. (IMVT) has a volatility of 25.85%. This indicates that NARI experiences smaller price fluctuations and is considered to be less risky than IMVT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%NovemberDecember2025FebruaryMarchApril0
25.85%
NARI
IMVT

Financials

NARI vs. IMVT - Financials Comparison

This section allows you to compare key financial metrics between Inari Medical, Inc. and Immunovant, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab